Crisprtx
2 known investors
CRISPR Therapeutics develops gene-based medicines using CRISPR technology to treat serious diseases, with a pipeline spanning hemoglobinopathies, oncology, diabetes, and cardiovascular disease. Its portfolio includes one approved therapy alongside multiple clinical and preclinical programs.